NCT00826436已完成不适用
A Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of PRA-027 Administered Orally to Japanese Postmenopausal Women
Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 16 人开始时间: 2008年11月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 16
- 主要终点
- To assess the safety and tolerability of multiple oral doses of PRA-027 in postmenopausal women.
研究概览
简要总结
The primary purpose of this study is to assess the safety and tolerability of ascending, multiple, oral doses of PRA-027 in Japanese postmenopausal women. The secondary purpose is to evaluate the PK and PD profile of multiple oral doses of PRA-027 in Japanese postmenopausal women.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 35 Years 至 65 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
To assess the safety and tolerability of multiple oral doses of PRA-027 in postmenopausal women.
时间窗: 28 days
次要结局
- To evaluate the Pharmacokinetics and Pharmacodynamics profile of multiple oral doses of PRA-027 in postmenopausal women.(28 days)
研究者
相似试验
终止
1 期
A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3Spinocerebellar Ataxia Type 3NCT05160558Biogen8
已完成
1 期
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending, Subcutaneous, Single and Multiple Doses of SHP681 (Glucagon-like Peptide-2 [GLP-2] Analog-Fc Fusion) in Healthy Adult ParticipantsHealthy VolunteersNCT03859323Shire104
已完成
1 期
A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy VolunteersHealthyNCT02953132Mitsubishi Tanabe Pharma Corporation116
已完成
1 期
A Study of E2086 in Healthy Adult ParticipantsHealthy VolunteersNCT06481488Eisai Inc.32
已完成
2 期
A Phase 2a Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Adults With AsthmaAsthmaNCT00783289MedImmune LLC35